Last reviewed · How we verify
NCT04431310
Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic
trial testing Serial seroconversion measurements in hospital employees during the COVID-19 pandemic in Covid-19 in 300 participants. Status unknown.
1 August 2025
Quick facts
| Lead sponsor | Nordsjaellands Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 27 March 2020 |
| Primary completion | 1 August 2025 |
| Estimated completion | 1 August 2025 |
| Sites | 2 locations across Denmark |
Drugs / interventions tested
- Serial seroconversion measurements in hospital employees during the COVID-19 pandemic
Conditions studied
- Covid-19 — all drugs for Covid-19 →
- Health Personnel — all drugs for Health Personnel →
- Personnel, Hospital — all drugs for Personnel, Hospital →
Sponsor
Nordsjaellands Hospital
Who can join
18 and older, any sex, with Covid-19 or Health Personnel. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to apply serology testing methods for SARS-CoV2 antibodies in samples collected from HCWs in an acute hospital. This will enable the identification of those who are protected and non-infectious for SARS-CoV2 and those who are seronegative and therefore potentially susceptible and infectious on patient contact. Prospective testing will provide data on the acquisition of SARS-CoV2 infections among HCWs and associated risk factors for transmission during a pandemic at an acute care hospital facility in the capital region of Denmark. Hypothesis: Serial seroconversion measurements in hospital employees improve the organization of the clinical treatment and care during the COVID-19 pandemic at Nordsjællands Hospital and Nykøbing Falster County Hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04431310
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid-19
Currently open trials in the same condition.
- NCT05943743 — Hiccups and Obstacles Of E-Learning Among Medical Sudents · recruiting
- NCT04466683 — Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia · Phase 2 · active not recruiting
- NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
- NCT04568148 — COVID-19 Biorepository · active not recruiting
- NCT04360538 — Long Term Outcomes of Patients With COVID-19 · active not recruiting
Other Nordsjaellands Hospital trials
Trials by the same sponsor.
- NCT07167498 — Continuous Remote Vital Sign Monitoring During Labour Analgesia With Remifentanil · not yet recruiting
- NCT07237984 — Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway · not yet recruiting
- NCT06689280 — Physical Rehabilitation of Older Persons Following a Community-Acquired Infection Hospitalization - A Randomised-Control · NA · not yet recruiting
- NCT06564857 — Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation · Phase 4 · recruiting
- NCT07132723 — Associations Between Time to Reduction and Complications in Patients With Dislocated Total Hip Arthroplasty · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04431310 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nordsjaellands Hospital
- Last refreshed: 16 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04431310.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing